Author Archives: Mauro Pavone

Human lung fibroblasts increase CD4(+)CD25(+)Foxp3(+) T cells in co-cultured CD4(+) lymphocytes.

http://www.ncbi.nlm.nih.gov/pubmed/24076465

Common pathways in idiopathic pulmonary fibrosis and cancer.

http://www.ncbi.nlm.nih.gov/pubmed/23997054

Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis.

http://www.ncbi.nlm.nih.gov/pubmed/23682111

Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors.

http://www.ncbi.nlm.nih.gov/pubmed/23659799

Differentiation of human adipose stem cells into neural phenotype by neuroblastoma- or olfactory ensheathing cells-conditioned medium.

http://www.ncbi.nlm.nih.gov/pubmed/23589068

Interferon-γ and interleukin-17 production from PPD-stimulated PBMCss of patients with pulmonary tuberculosis.

http://www.ncbi.nlm.nih.gov/pubmed/23544607

PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition.

http://www.ncbi.nlm.nih.gov/pubmed/23439433

Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung.

http://www.ncbi.nlm.nih.gov/pubmed/23320620

Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good.

http://www.ncbi.nlm.nih.gov/pubmed/23047830

Protective effects of thymosin β4 in a mouse model of lung fibrosis.

http://www.ncbi.nlm.nih.gov/pubmed/23045972